No Data
No Data
Express News | China Securities Co.,Ltd. recommends focusing on investment opportunities in the medical device sector, and focusing on the direction and individual stocks with strong performance certainty.
Express News | China Securities Co., Ltd.: Focus on investment opportunities in the medical devices, high-value consumables, and IVD (in-vitro diagnostic) fields.
Express News | China Securities Co., Ltd.: Domestic equipment procurement demand awaits recovery, focusing on the growth logic of innovative large products.
Shanghai Bio-heart Biological Technology Shrinks H1 Loss
Performance: P HA (02185.HK) narrowed its losses in the first half of the year to CNY 25.83 million.
Baxinan-B (02185.HK) released its mid-year performance for the six months ended in June, recording other income and revenue of RMB 1.42 million (the same below). The loss narrowed from RMB 86.19 million in the same period last year to RMB 25.83 million, with a loss per share of 11 points. No interim dividend will be distributed.
Bai Xin An -B (02185) announced its interim performance. The loss attributable to the parent company's owners was 25.83 million yuan, with a year-on-year narrowing of 70%.
Baixinan-B (02185) announced its mid-term performance in 2024, with R&D spending of approximately RMB 21.8 million (adjusted for inflation). ...
No Data
No Data